Consumer attitudes towards deprescribing: a systematic review and meta-analysis

KR Weir, NJ Ailabouni, CR Schneider… - The Journals of …, 2022 - academic.oup.com
Background Harmful and/or unnecessary medication use in older adults is common. This
indicates deprescribing (supervised withdrawal of inappropriate medicines) is not …

Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis

K Prokopidis, P Giannos, JY Reginster… - Journal of cachexia …, 2023 - Wiley Online Library
Polypharmacy in older adults is associated with multiple negative consequences that may
affect muscular function, independently from the presence of medical conditions. The aim of …

Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia: a comprehensive literature review

S Ruangritchankul, P Chantharit… - … and clinical risk …, 2021 - Taylor & Francis
The rising of global geriatric population has contributed to increased prevalence of
dementia. Dementia is a neurodegenerative disease, which is characterized by progressive …

[HTML][HTML] Diet for the prevention and management of sarcopenia

R Calvani, A Picca, HJ Coelho-Júnior, M Tosato… - Metabolism, 2023 - Elsevier
Sarcopenia is a geriatric condition characterized by a progressive loss of skeletal muscle
mass and strength, with an increased risk of adverse health outcomes (eg, falls, disability …

Sarcopenia and polypharmacy among older adults: a sco** review of the literature

A Pana, P Sourtzi, A Kalokairinou… - Archives of Gerontology …, 2022 - Elsevier
Background Sarcopenia and polypharmacy are both prevalent conditions in the geriatric
population, leading to poor quality of life and adverse outcomes. Objective To explore the …

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group …

J Tamargo, KP Kjeldsen, E Delpón… - European Heart …, 2022 - academic.oup.com
Population ageing has resulted in an increasing number of older people living with chronic
diseases (multimorbidity) requiring five or more medications daily (polypharmacy). Ageing …

Polypharmacy with potentially inappropriate medications as a risk factor of new onset sarcopenia among community-dwelling Japanese older adults: a 9-year …

T Tanaka, M Akishita, T Kojima, BK Son, K Iijima - BMC geriatrics, 2023 - Springer
Background Clinical evidence demonstrating a longitudinal association between prescribed
medications and sarcopenia onset is lacking. We investigated the association of …

Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system …

Y Yang, S Wei, H Tian, J Cheng, Y Zhong… - Frontiers in …, 2024 - frontiersin.org
Background Donepezil in combination with memantine is a widely used clinical therapy for
moderate to severe dementia. However, real-world population data on the long-term safety …

[PDF][PDF] Potenziell inadäquate Medikation für ältere Menschen–PRISCUS 2.0

P Thürmann, NK Mann, A Zawinell… - … 2022: Qualität der …, 2022 - library.oapen.org
Ältere Menschen über 65 Jahre stellen heute einen Anteil von 22, 4% an allen 72, 4Mio.
gesetzlich krankenversicherten Personen. Ihre Arzneimittelversorgung ist geprägt durch die …

Frailty and HIV: moving from characterization to intervention

KM Erlandson, DA Piggott - Current HIV/AIDS Reports, 2021 - Springer
Abstract Purpose of Review While the characteristics associated with frailty in people with
HIV (PWH) have been well described, little is known regarding interventions to slow or …